These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

333 related articles for article (PubMed ID: 22015471)

  • 21. Repeated-Dose Oral N-Acetylcysteine in Parkinson's Disease: Pharmacokinetics and Effect on Brain Glutathione and Oxidative Stress.
    Coles LD; Tuite PJ; Öz G; Mishra UR; Kartha RV; Sullivan KM; Cloyd JC; Terpstra M
    J Clin Pharmacol; 2018 Feb; 58(2):158-167. PubMed ID: 28940353
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Peripheral oxidative damage in mild cognitive impairment and mild Alzheimer's disease.
    Baldeiras I; Santana I; Proença MT; Garrucho MH; Pascoal R; Rodrigues A; Duro D; Oliveira CR
    J Alzheimers Dis; 2008 Sep; 15(1):117-28. PubMed ID: 18780972
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Strategy to reduce free radical species in Alzheimer's disease: an update of selected antioxidants.
    Di Domenico F; Barone E; Perluigi M; Butterfield DA
    Expert Rev Neurother; 2015 Jan; 15(1):19-40. PubMed ID: 25243342
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Evidence for oxidative and not reductive stress in the aged rabbit heart.
    Lapenna D; Ciofani G; Lelli Chiesa P; Porreca E
    Exp Gerontol; 2020 Feb; 134():110871. PubMed ID: 32035990
    [TBL] [Abstract][Full Text] [Related]  

  • 25. In-vivo glutathione elevation protects against hydroxyl free radical-induced protein oxidation in rat brain.
    Pocernich CB; La Fontaine M; Butterfield DA
    Neurochem Int; 2000 Mar; 36(3):185-91. PubMed ID: 10676851
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Impaired synthesis contributes to diabetes-induced decrease in liver glutathione.
    Furfaro AL; Nitti M; Marengo B; Domenicotti C; Cottalasso D; Marinari UM; Pronzato MA; Traverso N
    Int J Mol Med; 2012 May; 29(5):899-905. PubMed ID: 22344537
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Existing and potential therapeutic uses for N-acetylcysteine: the need for conversion to intracellular glutathione for antioxidant benefits.
    Rushworth GF; Megson IL
    Pharmacol Ther; 2014 Feb; 141(2):150-9. PubMed ID: 24080471
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Damage to lipids, proteins, DNA, and RNA in mild cognitive impairment.
    Markesbery WR; Lovell MA
    Arch Neurol; 2007 Jul; 64(7):954-6. PubMed ID: 17620484
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The differential expression of apoptosis factors in the alveolar epithelium is redox sensitive and requires NF-kappaB (RelA)-selective targeting.
    Haddad JJ; Land SC
    Biochem Biophys Res Commun; 2000 Apr; 271(1):257-67. PubMed ID: 10777712
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Antioxidants for the treatment of mild cognitive impairment.
    Mecocci P; Mariani E; Cornacchiola V; Polidori MC
    Neurol Res; 2004 Jul; 26(5):598-602. PubMed ID: 15265281
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Therapeutic potential of N-acetyl cysteine with antioxidants (Zn and Se) supplementation against dimethylmercury toxicity in male albino rats.
    Joshi D; Mittal DK; Shukla S; Srivastav AK
    Exp Toxicol Pathol; 2012 Jan; 64(1-2):103-8. PubMed ID: 20688495
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Melatonin attenuates diabetes-induced oxidative stress in rabbits.
    Winiarska K; Fraczyk T; Malinska D; Drozak J; Bryla J
    J Pineal Res; 2006 Mar; 40(2):168-76. PubMed ID: 16441554
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Nutritional antioxidants and the heme oxygenase pathway of stress tolerance: novel targets for neuroprotection in Alzheimer's disease.
    Calabrese V; Butterfield DA; Stella AM
    Ital J Biochem; 2003 Dec; 52(4):177-81. PubMed ID: 15141484
    [TBL] [Abstract][Full Text] [Related]  

  • 34. gamma-Glutamylcysteine ethyl ester for myocardial protection in dogs during ischemia and reperfusion.
    Hoshida S; Kuzuya T; Yamashita N; Nishida M; Kitahara S; Hori M; Kamada T; Tada M
    J Am Coll Cardiol; 1994 Nov; 24(5):1391-7. PubMed ID: 7930265
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effect of dietary supplementation of dates in Alzheimer's disease APPsw/2576 transgenic mice on oxidative stress and antioxidant status.
    Subash S; Essa MM; Al-Asmi A; Al-Adawi S; Vaishnav R; Guillemin GJ
    Nutr Neurosci; 2015 Aug; 18(6):281-8. PubMed ID: 24954036
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Oxidation pathway and exacerbations in COPD: the role of NAC.
    Matera MG; Calzetta L; Cazzola M
    Expert Rev Respir Med; 2016; 10(1):89-97. PubMed ID: 26567752
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effect of chronic N-acetyl cysteine administration on oxidative status in the presence and absence of induced oxidative stress in rat striatum.
    Harvey BH; Joubert C; du Preez JL; Berk M
    Neurochem Res; 2008 Mar; 33(3):508-17. PubMed ID: 17763945
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Metals, oxidative stress and neurodegenerative disorders.
    Jomova K; Vondrakova D; Lawson M; Valko M
    Mol Cell Biochem; 2010 Dec; 345(1-2):91-104. PubMed ID: 20730621
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Brain oxidative stress in a triple-transgenic mouse model of Alzheimer disease.
    Resende R; Moreira PI; Proença T; Deshpande A; Busciglio J; Pereira C; Oliveira CR
    Free Radic Biol Med; 2008 Jun; 44(12):2051-7. PubMed ID: 18423383
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Oxidative stress impairs glutamate uptake in fibroblasts from patients with Alzheimer's disease.
    Begni B; Brighina L; Sirtori E; Fumagalli L; Andreoni S; Beretta S; Oster T; Malaplate-Armand C; Isella V; Appollonio I; Ferrarese C
    Free Radic Biol Med; 2004 Sep; 37(6):892-901. PubMed ID: 15304259
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.